Ambuja Cements Limited (NSE: AMBUJACEM.NS) Stock Competitors & Peer Comparison

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ULTRACEMCO.NS has a market cap of 3.4T. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ULTRACEMCO.NS trades at ₹11,570.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ULTRACEMCO.NS's P/E ratio is 41.58. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ULTRACEMCO.NS's ROE of +0.11%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to ULTRACEMCO.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ULTRACEMCO.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ULTRACEMCO.BO has a market cap of 3.4T. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ULTRACEMCO.BO trades at ₹11,551.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ULTRACEMCO.BO's P/E ratio is 43.62. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ULTRACEMCO.BO's ROE of +0.11%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to ULTRACEMCO.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ULTRACEMCO.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, GRASIM.BO has a market cap of 2.3T. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while GRASIM.BO trades at ₹3,308.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas GRASIM.BO's P/E ratio is 546.78. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to GRASIM.BO's ROE of +0.04%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to GRASIM.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check GRASIM.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, GRASIM.NS has a market cap of 2.2T. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while GRASIM.NS trades at ₹3,308.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas GRASIM.NS's P/E ratio is 568.35. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to GRASIM.NS's ROE of +0.04%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to GRASIM.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check GRASIM.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, AMBUJACEM.BO has a market cap of 1T. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while AMBUJACEM.BO trades at ₹414.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas AMBUJACEM.BO's P/E ratio is 21.84. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to AMBUJACEM.BO's ROE of +0.07%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to AMBUJACEM.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check AMBUJACEM.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SHREECEM.NS has a market cap of 876B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SHREECEM.NS trades at ₹24,280.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SHREECEM.NS's P/E ratio is 56.16. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SHREECEM.NS's ROE of +0.07%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to SHREECEM.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SHREECEM.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SHREECEM.BO has a market cap of 873.4B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SHREECEM.BO trades at ₹24,178.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SHREECEM.BO's P/E ratio is 57.18. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SHREECEM.BO's ROE of +0.07%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to SHREECEM.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SHREECEM.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, JKCEMENT.BO has a market cap of 406.4B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while JKCEMENT.BO trades at ₹5,254.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas JKCEMENT.BO's P/E ratio is 41.29. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to JKCEMENT.BO's ROE of +0.14%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to JKCEMENT.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check JKCEMENT.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, JKCEMENT.NS has a market cap of 405.7B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while JKCEMENT.NS trades at ₹5,250.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas JKCEMENT.NS's P/E ratio is 41.25. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to JKCEMENT.NS's ROE of +0.14%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to JKCEMENT.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check JKCEMENT.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, DALBHARAT.NS has a market cap of 352.6B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while DALBHARAT.NS trades at ₹1,880.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas DALBHARAT.NS's P/E ratio is 30.81. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to DALBHARAT.NS's ROE of +0.05%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to DALBHARAT.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check DALBHARAT.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, DALBHARAT.BO has a market cap of 352B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while DALBHARAT.BO trades at ₹1,878.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas DALBHARAT.BO's P/E ratio is 29.68. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to DALBHARAT.BO's ROE of +0.05%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to DALBHARAT.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check DALBHARAT.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ACC.BO has a market cap of 246B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ACC.BO trades at ₹1,307.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ACC.BO's P/E ratio is 11.50. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ACC.BO's ROE of +0.10%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to ACC.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ACC.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ACC.NS has a market cap of 245.5B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ACC.NS trades at ₹1,307.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ACC.NS's P/E ratio is 12.73. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ACC.NS's ROE of +0.10%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to ACC.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ACC.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, RAMCOCEM.NS has a market cap of 212.4B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while RAMCOCEM.NS trades at ₹899.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas RAMCOCEM.NS's P/E ratio is 127.52. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to RAMCOCEM.NS's ROE of +0.08%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to RAMCOCEM.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check RAMCOCEM.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, RAMCOCEM.BO has a market cap of 212.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while RAMCOCEM.BO trades at ₹898.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas RAMCOCEM.BO's P/E ratio is 126.13. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to RAMCOCEM.BO's ROE of +0.08%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to RAMCOCEM.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check RAMCOCEM.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, KAJARIACER.NS has a market cap of 192.5B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while KAJARIACER.NS trades at ₹1,208.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas KAJARIACER.NS's P/E ratio is 32.82. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to KAJARIACER.NS's ROE of +0.19%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to KAJARIACER.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check KAJARIACER.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, KAJARIACER.BO has a market cap of 192.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while KAJARIACER.BO trades at ₹1,207.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas KAJARIACER.BO's P/E ratio is 36.46. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to KAJARIACER.BO's ROE of +0.19%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to KAJARIACER.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check KAJARIACER.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, JSWCEMENT.BO has a market cap of 169.1B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while JSWCEMENT.BO trades at ₹126.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas JSWCEMENT.BO's P/E ratio is 34.45. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to JSWCEMENT.BO's ROE of +0.15%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to JSWCEMENT.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check JSWCEMENT.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, JSWCEMENT.NS has a market cap of 169.1B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while JSWCEMENT.NS trades at ₹126.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas JSWCEMENT.NS's P/E ratio is 22.71. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to JSWCEMENT.NS's ROE of +0.15%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to JSWCEMENT.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check JSWCEMENT.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, NUVOCO.NS has a market cap of 115B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while NUVOCO.NS trades at ₹322.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas NUVOCO.NS's P/E ratio is 26.73. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to NUVOCO.NS's ROE of +0.04%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to NUVOCO.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check NUVOCO.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, INDIACEM.NS has a market cap of 114.9B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while INDIACEM.NS trades at ₹370.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas INDIACEM.NS's P/E ratio is 283.44. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to INDIACEM.NS's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to INDIACEM.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check INDIACEM.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, INDIACEM.BO has a market cap of 114.9B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while INDIACEM.BO trades at ₹370.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas INDIACEM.BO's P/E ratio is -4960.52. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to INDIACEM.BO's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to INDIACEM.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check INDIACEM.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, NUVOCO.BO has a market cap of 114.8B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while NUVOCO.BO trades at ₹321.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas NUVOCO.BO's P/E ratio is 26.71. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to NUVOCO.BO's ROE of +0.04%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to NUVOCO.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check NUVOCO.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, STARCEMENT.BO has a market cap of 78.7B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while STARCEMENT.BO trades at ₹194.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas STARCEMENT.BO's P/E ratio is 20.64. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to STARCEMENT.BO's ROE of +0.12%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to STARCEMENT.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check STARCEMENT.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, STARCEMENT.NS has a market cap of 78.7B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while STARCEMENT.NS trades at ₹194.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas STARCEMENT.NS's P/E ratio is 20.57. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to STARCEMENT.NS's ROE of +0.12%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to STARCEMENT.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check STARCEMENT.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, JKLAKSHMI.BO has a market cap of 69.5B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while JKLAKSHMI.BO trades at ₹558.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas JKLAKSHMI.BO's P/E ratio is 18.07. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to JKLAKSHMI.BO's ROE of +0.10%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to JKLAKSHMI.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check JKLAKSHMI.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, JKLAKSHMI.NS has a market cap of 69.5B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while JKLAKSHMI.NS trades at ₹559.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas JKLAKSHMI.NS's P/E ratio is 18.59. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to JKLAKSHMI.NS's ROE of +0.10%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to JKLAKSHMI.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check JKLAKSHMI.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, BIRLACORPN.NS has a market cap of 68.5B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while BIRLACORPN.NS trades at ₹889.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas BIRLACORPN.NS's P/E ratio is 12.03. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to BIRLACORPN.NS's ROE of +0.08%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to BIRLACORPN.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check BIRLACORPN.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, BIRLACORPN.BO has a market cap of 68.2B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while BIRLACORPN.BO trades at ₹890.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas BIRLACORPN.BO's P/E ratio is 12.05. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to BIRLACORPN.BO's ROE of +0.08%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to BIRLACORPN.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check BIRLACORPN.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, PRSMJOHNSN.NS has a market cap of 54.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while PRSMJOHNSN.NS trades at ₹107.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas PRSMJOHNSN.NS's P/E ratio is 56.23. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to PRSMJOHNSN.NS's ROE of +0.11%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to PRSMJOHNSN.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check PRSMJOHNSN.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, PRSMJOHNSN.BO has a market cap of 54.1B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while PRSMJOHNSN.BO trades at ₹107.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas PRSMJOHNSN.BO's P/E ratio is 48.82. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to PRSMJOHNSN.BO's ROE of +0.11%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to PRSMJOHNSN.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check PRSMJOHNSN.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, GREENPLY.BO has a market cap of 36.7B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while GREENPLY.BO trades at ₹294.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas GREENPLY.BO's P/E ratio is 36.67. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to GREENPLY.BO's ROE of +0.11%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to GREENPLY.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check GREENPLY.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, GREENPLY.NS has a market cap of 36.7B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while GREENPLY.NS trades at ₹293.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas GREENPLY.NS's P/E ratio is 36.46. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to GREENPLY.NS's ROE of +0.11%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to GREENPLY.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check GREENPLY.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, HEIDELBERG.NS has a market cap of 36B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while HEIDELBERG.NS trades at ₹158.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas HEIDELBERG.NS's P/E ratio is 30.11. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to HEIDELBERG.NS's ROE of +0.09%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to HEIDELBERG.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check HEIDELBERG.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, HEIDELBERG.BO has a market cap of 36B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while HEIDELBERG.BO trades at ₹159.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas HEIDELBERG.BO's P/E ratio is 30.00. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to HEIDELBERG.BO's ROE of +0.09%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to HEIDELBERG.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check HEIDELBERG.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, RAMCOIND.NS has a market cap of 30.1B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while RAMCOIND.NS trades at ₹347.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas RAMCOIND.NS's P/E ratio is 9.81. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to RAMCOIND.NS's ROE of +0.07%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to RAMCOIND.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check RAMCOIND.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, RAMCOIND.BO has a market cap of 30.1B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while RAMCOIND.BO trades at ₹346.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas RAMCOIND.BO's P/E ratio is 9.81. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to RAMCOIND.BO's ROE of +0.07%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to RAMCOIND.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check RAMCOIND.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, FINOLEXIND.BO has a market cap of 29.6B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while FINOLEXIND.BO trades at ₹238.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas FINOLEXIND.BO's P/E ratio is 9.34. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to FINOLEXIND.BO's ROE of +0.04%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to FINOLEXIND.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check FINOLEXIND.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, MANGLMCEM.NS has a market cap of 28.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while MANGLMCEM.NS trades at ₹1,027.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas MANGLMCEM.NS's P/E ratio is 18.23. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to MANGLMCEM.NS's ROE of +0.12%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to MANGLMCEM.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check MANGLMCEM.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, MANGLMCEM.BO has a market cap of 28.1B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while MANGLMCEM.BO trades at ₹1,025.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas MANGLMCEM.BO's P/E ratio is 18.18. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to MANGLMCEM.BO's ROE of +0.12%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to MANGLMCEM.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check MANGLMCEM.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, POKARNA.NS has a market cap of 27.8B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while POKARNA.NS trades at ₹897.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas POKARNA.NS's P/E ratio is 34.53. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to POKARNA.NS's ROE of +0.11%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to POKARNA.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check POKARNA.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, POKARNA.BO has a market cap of 27.7B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while POKARNA.BO trades at ₹895.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas POKARNA.BO's P/E ratio is 34.46. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to POKARNA.BO's ROE of +0.11%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to POKARNA.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check POKARNA.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ORIENTCEM.BO has a market cap of 27B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ORIENTCEM.BO trades at ₹131.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ORIENTCEM.BO's P/E ratio is 12.40. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ORIENTCEM.BO's ROE of +0.10%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to ORIENTCEM.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ORIENTCEM.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ORIENTCEM.NS has a market cap of 27B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ORIENTCEM.NS trades at ₹131.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ORIENTCEM.NS's P/E ratio is 12.41. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ORIENTCEM.NS's ROE of +0.10%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to ORIENTCEM.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ORIENTCEM.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, NITCO.BO has a market cap of 22.5B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while NITCO.BO trades at ₹93.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas NITCO.BO's P/E ratio is 88.95. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to NITCO.BO's ROE of -0.10%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to NITCO.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check NITCO.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, NITCO.NS has a market cap of 22.5B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while NITCO.NS trades at ₹93.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas NITCO.NS's P/E ratio is -98.82. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to NITCO.NS's ROE of -0.10%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to NITCO.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check NITCO.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SOMANYCERA.BO has a market cap of 21.4B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SOMANYCERA.BO trades at ₹520.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SOMANYCERA.BO's P/E ratio is 20.01. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SOMANYCERA.BO's ROE of +0.13%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to SOMANYCERA.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SOMANYCERA.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SOMANYCERA.NS has a market cap of 21.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SOMANYCERA.NS trades at ₹520.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SOMANYCERA.NS's P/E ratio is 19.88. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SOMANYCERA.NS's ROE of +0.13%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to SOMANYCERA.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SOMANYCERA.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SAGCEM.NS has a market cap of 21.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SAGCEM.NS trades at ₹162.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SAGCEM.NS's P/E ratio is -155.19. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SAGCEM.NS's ROE of -0.02%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to SAGCEM.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SAGCEM.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SAGCEM.BO has a market cap of 21.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SAGCEM.BO trades at ₹162.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SAGCEM.BO's P/E ratio is -155.10. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SAGCEM.BO's ROE of -0.02%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to SAGCEM.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SAGCEM.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, UDAICEMENT.NS has a market cap of 20.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while UDAICEMENT.NS trades at ₹36.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas UDAICEMENT.NS's P/E ratio is 201.28. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to UDAICEMENT.NS's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to UDAICEMENT.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check UDAICEMENT.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, UDAICEMENT.BO has a market cap of 20.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while UDAICEMENT.BO trades at ₹36.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas UDAICEMENT.BO's P/E ratio is 201.06. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to UDAICEMENT.BO's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to UDAICEMENT.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check UDAICEMENT.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, IFGLEXPOR.BO has a market cap of 15.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while IFGLEXPOR.BO trades at ₹213.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas IFGLEXPOR.BO's P/E ratio is 37.32. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to IFGLEXPOR.BO's ROE of +0.04%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to IFGLEXPOR.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check IFGLEXPOR.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, IFGLEXPOR.NS has a market cap of 15.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while IFGLEXPOR.NS trades at ₹211.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas IFGLEXPOR.NS's P/E ratio is 37.28. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to IFGLEXPOR.NS's ROE of +0.04%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to IFGLEXPOR.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check IFGLEXPOR.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ASIANTILES.BO has a market cap of 14.1B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ASIANTILES.BO trades at ₹47.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ASIANTILES.BO's P/E ratio is 47.47. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ASIANTILES.BO's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to ASIANTILES.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ASIANTILES.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ASIANTILES.NS has a market cap of 14.1B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ASIANTILES.NS trades at ₹47.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ASIANTILES.NS's P/E ratio is 25.35. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ASIANTILES.NS's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to ASIANTILES.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ASIANTILES.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SANGHIIND.BO has a market cap of 13B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SANGHIIND.BO trades at ₹50.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SANGHIIND.BO's P/E ratio is -4.97. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SANGHIIND.BO's ROE of -0.77%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to SANGHIIND.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SANGHIIND.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SANGHIIND.NS has a market cap of 12.9B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SANGHIIND.NS trades at ₹49.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SANGHIIND.NS's P/E ratio is -7.38. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SANGHIIND.NS's ROE of -0.77%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to SANGHIIND.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SANGHIIND.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, BIRLANU.NS has a market cap of 11.4B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while BIRLANU.NS trades at ₹1,514.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas BIRLANU.NS's P/E ratio is -10.49. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to BIRLANU.NS's ROE of -0.10%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to BIRLANU.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check BIRLANU.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, BIRLANU.BO has a market cap of 11.4B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while BIRLANU.BO trades at ₹1,511.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas BIRLANU.BO's P/E ratio is -18.37. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to BIRLANU.BO's ROE of -0.04%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to BIRLANU.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check BIRLANU.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SHREDIGCEM.NS has a market cap of 10.7B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SHREDIGCEM.NS trades at ₹72.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SHREDIGCEM.NS's P/E ratio is 59.34. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SHREDIGCEM.NS's ROE of +0.05%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to SHREDIGCEM.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SHREDIGCEM.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SHREDIGCEM.BO has a market cap of 10.7B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SHREDIGCEM.BO trades at ₹72.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SHREDIGCEM.BO's P/E ratio is 59.02. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SHREDIGCEM.BO's ROE of +0.05%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to SHREDIGCEM.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SHREDIGCEM.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, APOLLOPIPES.BO has a market cap of 9B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while APOLLOPIPES.BO trades at ₹686.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas APOLLOPIPES.BO's P/E ratio is 46.89. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to APOLLOPIPES.BO's ROE of +0.08%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to APOLLOPIPES.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check APOLLOPIPES.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, VISAKAIND.BO has a market cap of 8.2B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while VISAKAIND.BO trades at ₹94.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas VISAKAIND.BO's P/E ratio is 9.57. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to VISAKAIND.BO's ROE of +0.11%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to VISAKAIND.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check VISAKAIND.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, VISAKAIND.NS has a market cap of 8.2B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while VISAKAIND.NS trades at ₹94.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas VISAKAIND.NS's P/E ratio is 9.57. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to VISAKAIND.NS's ROE of +0.11%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to VISAKAIND.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check VISAKAIND.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, NCLIND.NS has a market cap of 7.9B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while NCLIND.NS trades at ₹174.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas NCLIND.NS's P/E ratio is 8.06. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to NCLIND.NS's ROE of +0.10%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to NCLIND.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check NCLIND.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, NCLIND.BO has a market cap of 7.8B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while NCLIND.BO trades at ₹173.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas NCLIND.BO's P/E ratio is 8.05. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to NCLIND.BO's ROE of +0.10%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to NCLIND.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check NCLIND.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, DECCANCE.BO has a market cap of 7.8B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while DECCANCE.BO trades at ₹553.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas DECCANCE.BO's P/E ratio is 27.11. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to DECCANCE.BO's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to DECCANCE.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check DECCANCE.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, DECCANCE.NS has a market cap of 7.8B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while DECCANCE.NS trades at ₹554.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas DECCANCE.NS's P/E ratio is 27.16. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to DECCANCE.NS's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to DECCANCE.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check DECCANCE.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SEJALLTD.BO has a market cap of 7.7B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SEJALLTD.BO trades at ₹667.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SEJALLTD.BO's P/E ratio is 24.30. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SEJALLTD.BO's ROE of +0.30%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to SEJALLTD.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SEJALLTD.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SEJALLTD.NS has a market cap of 7.6B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SEJALLTD.NS trades at ₹663.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SEJALLTD.NS's P/E ratio is 61.13. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SEJALLTD.NS's ROE of +0.30%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to SEJALLTD.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SEJALLTD.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, EVERESTIND.BO has a market cap of 6.9B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while EVERESTIND.BO trades at ₹439.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas EVERESTIND.BO's P/E ratio is -6.85. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to EVERESTIND.BO's ROE of -0.00%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to EVERESTIND.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check EVERESTIND.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, EVERESTIND.NS has a market cap of 6.9B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while EVERESTIND.NS trades at ₹434.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas EVERESTIND.NS's P/E ratio is -6.77. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to EVERESTIND.NS's ROE of -0.00%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to EVERESTIND.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check EVERESTIND.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SAURASHCEM.BO has a market cap of 6.5B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SAURASHCEM.BO trades at ₹58.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SAURASHCEM.BO's P/E ratio is 44.75. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SAURASHCEM.BO's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to SAURASHCEM.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SAURASHCEM.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SAURASHCEM.NS has a market cap of 6.5B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SAURASHCEM.NS trades at ₹58.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SAURASHCEM.NS's P/E ratio is 44.68. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SAURASHCEM.NS's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to SAURASHCEM.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SAURASHCEM.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, BIGBLOC.BO has a market cap of 6.1B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while BIGBLOC.BO trades at ₹42.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas BIGBLOC.BO's P/E ratio is -343.75. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to BIGBLOC.BO's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to BIGBLOC.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check BIGBLOC.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, BIGBLOC.NS has a market cap of 6B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while BIGBLOC.NS trades at ₹42.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas BIGBLOC.NS's P/E ratio is -343.19. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to BIGBLOC.NS's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to BIGBLOC.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check BIGBLOC.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ORIENTBELL.NS has a market cap of 5.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ORIENTBELL.NS trades at ₹359.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ORIENTBELL.NS's P/E ratio is 23.87. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ORIENTBELL.NS's ROE of +0.07%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to ORIENTBELL.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ORIENTBELL.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ORIENTBELL.BO has a market cap of 5.2B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ORIENTBELL.BO trades at ₹354.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ORIENTBELL.BO's P/E ratio is 23.70. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ORIENTBELL.BO's ROE of +0.07%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to ORIENTBELL.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ORIENTBELL.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SHIVACEM.BO has a market cap of 4.9B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SHIVACEM.BO trades at ₹16.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SHIVACEM.BO's P/E ratio is -4.36. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SHIVACEM.BO's ROE of -12.60%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to SHIVACEM.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SHIVACEM.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ACL.NS has a market cap of 4.2B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ACL.NS trades at ₹45.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ACL.NS's P/E ratio is -6.81. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ACL.NS's ROE of -0.94%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to ACL.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ACL.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ACL.BO has a market cap of 4.2B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ACL.BO trades at ₹45.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ACL.BO's P/E ratio is -6.22. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ACL.BO's ROE of -0.94%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to ACL.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ACL.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SAHYADRI.NS has a market cap of 4.1B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SAHYADRI.NS trades at ₹374.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SAHYADRI.NS's P/E ratio is 14.12. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SAHYADRI.NS's ROE of +0.11%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to SAHYADRI.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SAHYADRI.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, SAHYADRI.BO has a market cap of 4.1B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while SAHYADRI.BO trades at ₹373.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas SAHYADRI.BO's P/E ratio is 14.09. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to SAHYADRI.BO's ROE of +0.11%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to SAHYADRI.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check SAHYADRI.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, EUROBOND.NS has a market cap of 3.9B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while EUROBOND.NS trades at ₹157.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas EUROBOND.NS's P/E ratio is 14.52. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to EUROBOND.NS's ROE of +0.18%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to EUROBOND.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check EUROBOND.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ZODIAC.BO has a market cap of 3.8B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ZODIAC.BO trades at ₹250.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ZODIAC.BO's P/E ratio is 124.38. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ZODIAC.BO's ROE of +0.24%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to ZODIAC.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ZODIAC.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, VISHNUINFR.NS has a market cap of 3.8B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while VISHNUINFR.NS trades at ₹152.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas VISHNUINFR.NS's P/E ratio is 12.77. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to VISHNUINFR.NS's ROE of N/A. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to VISHNUINFR.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check VISHNUINFR.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ZODIAC.NS has a market cap of 3.7B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ZODIAC.NS trades at ₹247.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ZODIAC.NS's P/E ratio is 123.31. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ZODIAC.NS's ROE of +0.24%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to ZODIAC.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ZODIAC.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, KESORAMIND.BO has a market cap of 3.6B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while KESORAMIND.BO trades at ₹11.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas KESORAMIND.BO's P/E ratio is -4.05. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to KESORAMIND.BO's ROE of -0.03%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to KESORAMIND.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check KESORAMIND.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, KESORAMIND.NS has a market cap of 3.6B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while KESORAMIND.NS trades at ₹11.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas KESORAMIND.NS's P/E ratio is -4.05. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to KESORAMIND.NS's ROE of -0.03%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to KESORAMIND.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check KESORAMIND.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, NAVKAR.BO has a market cap of 3.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while NAVKAR.BO trades at ₹14.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas NAVKAR.BO's P/E ratio is 145.10. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to NAVKAR.BO's ROE of -0.02%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to NAVKAR.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check NAVKAR.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, APCL.BO has a market cap of 3.1B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while APCL.BO trades at ₹105.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas APCL.BO's P/E ratio is -10.73. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to APCL.BO's ROE of -0.13%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to APCL.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check APCL.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, APCL.NS has a market cap of 3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while APCL.NS trades at ₹102.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas APCL.NS's P/E ratio is -10.51. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to APCL.NS's ROE of -0.13%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to APCL.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check APCL.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, GSCLCEMENT.NS has a market cap of 3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while GSCLCEMENT.NS trades at ₹33.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas GSCLCEMENT.NS's P/E ratio is -87.37. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to GSCLCEMENT.NS's ROE of +0.04%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to GSCLCEMENT.NS. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check GSCLCEMENT.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, EXXARO.BO has a market cap of 2.8B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while EXXARO.BO trades at ₹6.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas EXXARO.BO's P/E ratio is 40.67. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to EXXARO.BO's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to EXXARO.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check EXXARO.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, EXXARO.NS has a market cap of 2.7B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while EXXARO.NS trades at ₹6.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas EXXARO.NS's P/E ratio is 8.81. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to EXXARO.NS's ROE of +0.01%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to EXXARO.NS. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check EXXARO.NS's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, AHMDSTE.BO has a market cap of 2.7B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while AHMDSTE.BO trades at ₹180.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas AHMDSTE.BO's P/E ratio is 13.28. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to AHMDSTE.BO's ROE of +0.14%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to AHMDSTE.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check AHMDSTE.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, ASIIL.BO has a market cap of 2.3B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while ASIIL.BO trades at ₹25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas ASIIL.BO's P/E ratio is 8.04. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to ASIIL.BO's ROE of +0.07%. Regarding short-term risk, AMBUJACEM.NS is less volatile compared to ASIIL.BO. This indicates lower risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check ASIIL.BO's competition here

Ambuja Cements Limited (NSE: AMBUJACEM.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMBUJACEM.NS stands at 1T. In comparison, MURUDCERA.BO has a market cap of 1.9B. Regarding current trading prices, AMBUJACEM.NS is priced at ₹414.50 on the NSE, while MURUDCERA.BO trades at ₹30.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMBUJACEM.NS currently has a P/E ratio of 22.90, whereas MURUDCERA.BO's P/E ratio is 16.64. In terms of profitability, AMBUJACEM.NS's ROE is +0.07%, compared to MURUDCERA.BO's ROE of +0.03%. Regarding short-term risk, AMBUJACEM.NS is more volatile compared to MURUDCERA.BO. This indicates higher risk in terms of short-term price fluctuations for AMBUJACEM.NS.Check MURUDCERA.BO's competition here